APA (7th ed.) Citation

Poh, M. E., Liam, C. K., Rajadurai, P., & Chai, C. S. (2018). Epithelial-to-mesenchymal transition (EMT) causing acquired resistance to afatinib in a patient with epidermal growth factor receptor (EGFR)-mutant lung adenocarcinoma. AME Publishing Company.

Chicago Style (17th ed.) Citation

Poh, Mau Ern, Chong Kin Liam, Pathmanathan Rajadurai, and Chee Shee Chai. Epithelial-to-mesenchymal Transition (EMT) Causing Acquired Resistance to Afatinib in a Patient with Epidermal Growth Factor Receptor (EGFR)-mutant Lung Adenocarcinoma. AME Publishing Company, 2018.

MLA (9th ed.) Citation

Poh, Mau Ern, et al. Epithelial-to-mesenchymal Transition (EMT) Causing Acquired Resistance to Afatinib in a Patient with Epidermal Growth Factor Receptor (EGFR)-mutant Lung Adenocarcinoma. AME Publishing Company, 2018.